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Use of a cAMP BRET Sensor to Characterize a Novel Regulation of cAMP by the 
Sphingosine-1-phosphate/G13 Pathway 
 
SUPPLEMENTAL DATA 
 
Characterization of the CAMYEL sensor and calculation of intracellular concentrations of cAMP 
from BRET ratios. The purified sensor was used to determine the Kd and Hill coefficient for association 
of cAMP with the sensor; these were 8.8 µΜ and 1, respectively (Fig. S1). The response of the sensor to 
cAMP was independent of pH in the range of 6.5-8.0 and not affected by calcium at concentrations up to 
1 mM (Fig. S2). The response time of the sensor was assessed by changes in BRET when the sensor was 
exposed to abrupt increases or decreases in cAMP. Such changes depend on both the association and 
dissociation of cAMP and the ensuing changes in conformation.  In vitro, the change in BRET in response 
to altered cAMP appears to be complete in 1 to 2 seconds (Fig. S3). This rate of signal change is well 
suited for measuring the kinetics of change in intracellular concentrations of cAMP.  
Ratiometric data was converted to cAMP concentration using the equation: 
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The Kd and n are 8.8 µΜ and 1, respectively (Fig. S1). R is the intensity ratio of RL to YFP. Rmax 
was obtained by adding 2 mM 8-Bromo cAMP to the cells at the end of the assay (Fig. 2B). An identical 
Rmax value can be obtained by lysing the cells with 0.1% NP-40 and adding a saturating amount of 
cAMP (2 mM) at the end of the assay. At this time an absolute value for Rmin can not be determined. 
However, the basal cAMP concentration in RAW 264.7 cells is very low and estimated to be in the range 
of 40-100 nM based on measurements of total cellular cAMP with the EIA and cell volume. The 
difference in BRET ratio at this concentration of cAMP vs. no cAMP falls within the error of our 
measurements. In addition, treatment with inhibitors of phosphodiesterases does not significantly alter 
basal cAMP in the cells as measured by both EIA and the CAMYEL sensor. Therefore, we arbitrarily set 
Rmin to be the average ratio of measurements with unstimulated cells minus 4 standard deviations. This 
ensures that Rmin is always less than the measured value. Note: measurements of total intracellular 
cAMP by EIA in unstimulated cells yield ~2 pmol/mg protein. The RAW 264.7 cells contain about 1mg 
protein per 107 cells and the cell volume was estimated by microscopy to be 2-5 pL. According to these 
numbers the basal intracellular concentration of cAMP is estimated to be 40-100 nM, much of it 
presumably bound to intracellular proteins.  
The validity of these calculations is supported by the fact that the Rmax to Rmin ratio calculated from 
live cell assays is the same as ratios for purified proteins and that the calculations for cAMP in stimulated 
samples are proportionally in agreement with the results from the EIA. In Figure 3A, a baseline BRET 
ratio of 1.53, which represents essentially unliganded sensor, could be stimulated to 2.61 when cells were 
saturated with 8-Bromo cAMP, an increase of about 70%. This magnitude of change is similar to what we 
observed with the purified protein in response to cAMP (Figure 1C). In Figure 3B, the ratios between 
various ligand-induced cAMP responses appear to be similar to those observed with the EIA as well. 
Finally, we determined the concentration-response relationships for ISO and S1P (Fig. S4). The EC50 for 
ISO was about 20 nM either in the presence or absence of S1P; the EC50 for S1P in the presence of 16 nM 
ISO was about 8 nM. These results are also similar to those determined by EIA. Based on these 
comparisons, we believe this approach to convert ratiometric measurements to actual concentrations of 
cAMP is valid.  
Independent validation of G13 involvement in the S1P synergy on cAMP. Knockdown of Gα13 using 
siRNA greatly reduced the S1P enhancement on cAMP synthesis as measured with the CAMYEL sensor. 
To independently validate the involvement of Gα13, we used a micro-RNA based shRNA delivered via 
retroviral infection to knockdown Gα13. The targeting sequence is 5’-TGGGTGAGTCTGTAAAGTA-
3’, which was independently selected from the siRNA sequences. In addition, we measured the 
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cAMP response using the EIA method. As shown in Supplementary Figure S5, the cAMP 
response to ISO and S1P was attenuated, while the response to ISO alone or ISO and UDP 
remained unchanged. 
Rho GTPase is not involved in the S1P enhancement on cAMP synthesis. Well-characterized 
downstream effectors of the G13 pathway are the Rho GTPases, which can mediate cytoskeleton 
rearrangement during chemotaxis, cell adhesion, phagocytosis and cell cycle progression (43,44). To 
assess the involvement of Rho proteins in the S1P effect on cAMP synthesis, we applied Clostridium 
difficile toxin B and a Rho kinase inhibitor, H1152, to block Rho and Rho kinase activity, respectively. 
As shown in figure S6A, none of the inhibitors affected the ability of S1P to enhance cAMP synthesis. 
The effectiveness of C. difficile toxin B to block activation of Rho was verified by direct assessment of 
the activated GTPase in response to S1P (Fig. S6B). Therefore, the synergistic effect of S1P on cAMP 
synthesis does not appear to involve Rho. 
The synergistic effect of S1P on cAMP exists in primary macrophages. To explore the physiological 
relevance of the S1P synergism on cAMP, we examined the cAMP responses in primary bone marrow-
derived macrophage (BMDM) cells. Not surprisingly this synergism is more profound in the BMDM 
cells, where addition of S1P boosted the production of cAMP triggered by ISO or PGE over 10-fold (Fig. 
S7). In these primary cells the synergistic effect was also more prolonged, lasting throughout the 5-minute 
period of assessment.  
 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Reagents. Clostridium difficile toxin B and H1152 were purchased from Calbiochem.  
Assay of activated Rho. Cells (1x106) were plated on 60 mm tissue culture dishes one day prior to the 
assay. On the day of assay, cells were cultured in serum-free medium with or without 10 ng/ml 
Clostridium difficile toxin B for 1 hour. Ligands were then added to stimulate the cells. Reactions were 
stopped after 1 minute of stimulation by rapid removal of medium and placement on ice; the cells were 
immediately washed with ice-cold 1xPBS and lysed with 200 µl lysis buffer. Cell lysates were cleared by 
brief centrifugation and assayed using the G-LISA RhoA activation assay kit (Cytoskeleton Inc.). 
Isolation of BMDM. Bone marrow derived primary macrophages were isolated from mouse femurs 
and cultured as described (49). 
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SUPPLEMENTAAL FIGURE LEGANDS 
 
Figure S1. Concentration dependence of BRET changes induced by cAMP or 8-Bromo-cAMP. Data 
plotted are averages of 3 experiments. Bacterial expressed protein with an N-terminal 6xHis tag was 
purified with Ni-NTA resin. Protein was diluted to 20 nM with buffer containing 20 mM NaHEPES, pH 
7.4, 50 mM KCl, 50 mM NaCl, 2.5 mM MgCl2, 0.2% NP-40, 5 mM DTT, protease inhibitors, and mixed 
with the indicated concentrations of the cyclic nucleotide and 2 µΜ coelenterazine-h before assay. The 
BRET signal was measured by simultaneous measurements at wavelengths of 475 nm and 535 nm using a 
POLARstar Optima. The BRET ratio is expressed as RL/YFP (475/535). The maximal change in BRET 
was similar for cAMP and 8-Bromo cAMP. When the Hill function equation was used to fit the data, a 
Kd for cAMP of 8.8 +/- 0.6 µM, a Kd for 8-Bromo cAMP of 1.8 +/- 0.2 µM and Hill coefficients of 0.97 
and 1.07, respectively, were obtained. 
 
Figure S2. The BRET ratio of CAMYEL sensor is not affected by changes in calcium concentration or 
pH. CAMYEL protein was diluted to 20 nM with buffer containing 20 mM NaHEPES, 50 mM KCl, 50 
mM NaCl, 2.5 mM MgCl2, 0.2% NP-40, 5 mM DTT, and protease inhibitors, at the indicated pH or with 
1mM calcium. The BRET signal was measured in the presence of 2 µM coelenterazine-h substrate with or 
without 100 µM cAMP. The BRET ratio is expressed as RL/YFP (475/535). 
 
Figure S3. Kinetics of cAMP-induced changes in BRET with the CAMYEL sensor protein. For 
measuring the kinetics of cAMP binding and associated changes in BRET, 50 µl of 20 nM CAMYEL 
protein was added to a well on a 96 well plate in the presence of 2 µΜ coelenterazine-h and RL/YFP 
ratios were measured using a POLARstar Optima. At the time indicated by the arrow, 2x cAMP was 
injected into the well at 420 µl per second to reach the indicated final cAMP concentration. For 
measuring the BRET changes induced by dissociation of cAMP from the CAMYEL protein, 30 µl of 50 
nM CAMYEL protein was added to a well on a 96 well plate in the presence of the indicated cAMP 
concentration and 5 µΜ coelenterazine-h and RL/YFP ratios were measured. At the time indicated by the 
arrow, 210 µl of buffer was injected into the well at 420 µl per second to reach the indicated final 
concentration of cAMP (1/8 of the initial concentration). 
 
Figure S4. Concentration response curves of RAW 264.7 cells as measured with the CAMYEL sensor. A, 
RAW cells expressing CAMYEL were stimulated with the indicated concentrations of S1P in the 
presence of 16 nM ISO. B, RAW cells expressing CAMYEL were stimulated with the indicated 
concentrations of ISO in the absence or presence of 10 nM S1P. The percent max peak response was 
calculated as the peak response divided by maximal peak response observed times 100. Data shown are 
averages of 3 experiments.  
 
Figure S5. G13 mediates the S1P synergy on cAMP as measured by EIA. RAW cells were infected with 
retrovirus expressing micro-RNA targeting Gα13  or non-targeting sequences (control). At time 0, cells 
were stimulated with 50 nM ISO (A), 50 nM ISO and 25 µM UDP (A), or 50 nM ISO and 1 µM S1P (B) 
as indicated. At the given times reactions were stopped by removal of medium and addition of cell lysis 
solution and cAMP was determined by EIA. Error bars represent the standard deviation of results from 5 
independent experiments. 
 
Figure S6. Inhibition of Rho activation did not affect the enhancement of cAMP responses by S1P. A, 
Cells were pretreated with 10 ng/ml Clostridium difficile toxin B (TxB) for 1 hour or 10 µM H1152 for 30 
minutes prior to assay. Cells were stimulated with 16 nM ISO followed by 10 nM S1P at times indicated 
by the arrows. Intracellular cAMP was measured with the CAMYEL sensor. Error bars represent the 
standard deviation of results from 4 experiments. B, Effectiveness of TxB treatment. Cells were 
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pretreated with TxB as described above followed by stimulation with 1 µM S1P. The reactions were 
stopped at 1 minute and cells were lysed and assayed for Rho activation using the G-LISA kit. Error bars 
represent the standard deviation of results from 3 experiments. 
 
Figure S7. Changes in cAMP in BMDM cells. At time 0, cells were stimulated with 16 nM ISO, 16 nM 
ISO and 10 nM S1P, 10 µΜ PGE, 10 µΜ PGE and 10 nM S1P, or 50 nM S1P as indicated. At the given 
times reactions were stopped by removal of medium and addition of cell lysis solution and cAMP was 
determined by EIA. The results shown are the average of 3 independent experiments done with two 
different preparations of cells: the variance among the experiments is about 30% of the signals. 
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Supplementary Figure S6 
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Supplementary Figure S7 
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